Amarin Corp Plc (AMRN)

[couldbebetter]

What AMRN failed to get across in promoting Vascepa:
1. Vascepa is a medication that accrues its Cardiovascular benefits over
time. In other words the longer a patient is taking the drug, the
better the potential benefit.
2. The best time to start taking Vascepa is at the earliest signs of CVD.
If a patient is at risk. For example, when a doctor decides its time
for a patients to be on a statin they should also begin Vascepa.
3. In order for a patients to continue taking Vascepa for the rest of
their life, they should understand WHY they should be doing it.
If the patients doctor does not understand the importance it is
unlikely that the patient will.

AMRN management has failed to get this critically important message
across to its sales reps, to doctors, or to patients. We have a
management team that was never qualified to launch a medication
so important. Hope Mr. Mikhail will be a competent CEO. Thero blew
this great opportunity "BIG TIME!"